The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes

Diabetes Technology and Therapeutics

Volumn 13, Issue 8, 2011, Pages 813-818

  Monnier, Louis ^a   Wojtusciszyn, Anne ^b   Colette, Claude ^a   Owens, David ^c  

^a Laboratory of Human Nutrition and Atherosclerosis   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN SENSITIZING AGENT; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GLUCOSE ASSAY; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS;

EID: 79960403329     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0049     Document Type: Article

References (25)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853. Erratum in: Lancet 1999;354:602.
2. The Action to Control Cardiovascular Risk in Diabetes Study Group: Effect of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
3. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139.
4. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. (Pubitemid 34000785)
5. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
6. Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, Horowitz KR, Savage PJ, Seaquist ER, Simons DL, Sivitz XI, Speril-Hillen JM, Sweeney ME: The association between symptomatic, severe hypoglycemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD Study. BMJ 2010;340:b4909. doi:10.1136/bmj.b4909.
7. UK Hypoglycaemia Study group: Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-1147.
8. Lebovitz HE: Insulin secretagogues: old and new. Diabetes 1999;7:139-153.
9. Schopman JE, Geddes J, Frier BM: Prevalence of impaired awareness of hypoglycemia and frequency of hypoglycemia in insulin-treated Type 2 diabetes. Diabetes Res Clin Pract 2010;87:64-68.
10. Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC: A probalistic model for predicting hypoglycemia in type 2 diabetes mellitus. The Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med 2004;164:1445-1450.
11. Code de la SantéPublique. Partie legislative. Premiére partie. Livre premier. Titre II, Chapitre 1, Article L-1121-1. April 18, 2006 (consolidated version of August 29, 2009). legifrance. com (accessed August 31, 2009).
12. Buckingham B, Block J, Wilson DM: Continuous glucose monitoring. Curr Opin Endocrinol Diabetes 2005;12:273-279. (Pubitemid 41225235)
13. Monnier L, Colette C, Boegner C, Pham TC, Lapinski H, Boniface H: Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? Diabetes Metab 2007;33:247-252. (Pubitemid 47418699)
14. American Diabetes Association Workshop on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005;28:1245-1249.
15. American Diabetes Association: Standards of medical care in diabetes-2011. Diabetes Care 2011;34(Suppl 1):S11-S61.
16. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-1912. (Pubitemid 36929141)
17. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002;25:889-893. (Pubitemid 41094288)
18. Service FJ, O'Brien PC, Rizza RA: Measurements of glucose control. Diabetes Care 1987;10:225-237. (Pubitemid 17065817)
19. Rodbard D: New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 2009;11:551-565.
20. Kilpatrick ES, Rigby AS, Goode K, Atkin SL: Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007;50:2553-2561. (Pubitemid 350060641)
21. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
22. Nordin C: The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 2010;53: 1553-1561.
23. Desouza CV, Bolli GB, Fonseca V: Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010;33:1389-1394.
24. Sacks DB, Bruns DE, Goldstein DE, MacLaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (position statement). Diabetes Care 2002;25:750-786. (Pubitemid 41071198)
25. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK; 4-T Study Group: Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009;361:1736-1747.